Sanofi-Synthelabo Group achieved 15% of sales up last year.

Published: 2004-02-19 06:56:00

Updated: 2004-02-19 06:56:00

Sanofi-Synthelabo group reported their business performances during 2003 on Feb. 17 describing, to compare to the previous year, 15.6% up of the net sales with 8,048 million Euro dollars (about 11 trillion won), 17.6% up of the ordinary profits, 17.7% up of the net profits with 2,069 million Euro...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK